Fujirebio’s Assay Complements Established Ovarian Cancer Tests
This article was originally published in The Gray Sheet
Executive Summary
When combined with an established assay, a new blood test made by Malvern, Pa.-based Fujirebio Diagnostics flags most epithelial ovarian cancers in women with a pelvic cyst or mass, researchers reported March 10 in Tampa, Fla., at the annual meeting of the Society of Gynecologic Oncologists